NCT05600127: Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 64 planned
- Started
- 1 Dec 2022
- Primary completion
- Apr 2025
- Arms
- Avelumab
- Results
- None posted
- 31 Oct 2022: Trial registered
- 1 Dec 2022: Trial started